140 related articles for article (PubMed ID: 16043736)
1. Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects.
Hernández C; Carrasco E; Casamitjana R; Deulofeu R; García-Arumí J; Simó R
Diabetes Care; 2005 Aug; 28(8):1941-7. PubMed ID: 16043736
[TBL] [Abstract][Full Text] [Related]
2. Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy.
Simó R; Lecube A; Sararols L; García-Arumí J; Segura RM; Casamitjana R; Hernández C
Diabetes Care; 2002 Dec; 25(12):2282-6. PubMed ID: 12453974
[TBL] [Abstract][Full Text] [Related]
3. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
[TBL] [Abstract][Full Text] [Related]
4. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema.
Hernández C; Fonollosa A; García-Ramírez M; Higuera M; Catalán R; Miralles A; García-Arumí J; Simó R
Diabetes Care; 2006 Sep; 29(9):2028-33. PubMed ID: 16936148
[TBL] [Abstract][Full Text] [Related]
6. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X
Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.
Katsura Y; Okano T; Noritake M; Kosano H; Nishigori H; Kado S; Matsuoka T
Diabetes Care; 1998 Oct; 21(10):1759-63. PubMed ID: 9773744
[TBL] [Abstract][Full Text] [Related]
8. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
[TBL] [Abstract][Full Text] [Related]
9. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
[TBL] [Abstract][Full Text] [Related]
11. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-binding protein and soluble CD14 in the vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Ortega F; García-Ramírez M; Villarroel M; Casado J; García-Pascual L; Fernández-Real JM; Simó R
Retina; 2010 Feb; 30(2):345-52. PubMed ID: 20175275
[TBL] [Abstract][Full Text] [Related]
13. Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.
Simó R; Higuera M; García-Ramírez M; Canals F; García-Arumí J; Hernández C
Arch Ophthalmol; 2008 Aug; 126(8):1076-81. PubMed ID: 18695102
[TBL] [Abstract][Full Text] [Related]
14. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
[TBL] [Abstract][Full Text] [Related]
16. Intravitreous leptin concentrations in patients with proliferative diabetic retinopathy.
Hernández C; Lecube A; Castellanos JM; Segura RM; Garat M; García-Arumí J; Simó R
Retina; 2004 Feb; 24(1):30-5. PubMed ID: 15076941
[TBL] [Abstract][Full Text] [Related]
17. Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy.
Hernández C; Carrasco E; García-Arumí J; Maria Segura R; Simó R
Diabetes Metab; 2004 Sep; 30(4):341-6. PubMed ID: 15525877
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab.
Ma Y; Zhang Y; Zhao T; Jiang YR
Am J Ophthalmol; 2012 Feb; 153(2):307-313.e2. PubMed ID: 21982107
[TBL] [Abstract][Full Text] [Related]
19. Increased D-serine in the aqueous and vitreous humour in patients with proliferative diabetic retinopathy.
Jiang H; Du J; He T; Qu J; Song Z; Wu S
Clin Exp Ophthalmol; 2014 Dec; 42(9):841-5. PubMed ID: 24645972
[TBL] [Abstract][Full Text] [Related]
20. [Vitreous levels of stromal cell-derived factor-1 and vascular endothelial growth factor in diabetic retinopathy].
Chen L; Lü L; Li Y; Huang X; Zhang J; Li S
Yan Ke Xue Bao; 2008 Mar; 24(1):6-8. PubMed ID: 18709948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
